Linked Life Data

7656808

Source:http://linkedlifedata.com/resource/pubmed/id/7656808

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1995-10-5
pubmed:abstractText
Sixty-five patients with stage II testicular seminoma treated from 1960 through 1990 were reviewed. According to Royal Marsden Hospital staging, there were 11 stage IIA, 13 stage IIB, and 41 stage IIC. Thirty Patients were treated with combination of radiotherapy and chemotherapy, 11 chemotherapy alone, 24 rediotherapy alone. The overall 5-year survival rate was 75.6%, with 100% for stage IIA, 92.3% for stage IIB and 62.9% for stage IIC. The differences were statistically significant. In stage IIC patients, there was no significant difference between those tumors > 10cm and < 10cm in diameter. Of the 41 IIC cases, 4 were treated with chemotherapy, 15 were treated with whole abdominal rediation, 22 with paraaortic and ipsilateral pelvic radiation. The 5-year survival rate was 91.7% and 51.2%, respectively. These differences was statistically significant. We recommand that stage IIC disease should be treated primarily with whole abdominal radiation. Regardless of the stage of the disease, prophylactic mediastinal irradiation did not influence the survival nor the relapse rate and may therefore be omitted.
pubmed:language
chi
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0253-3766
pubmed:author
pubmed:issnType
Print
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
142-5
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1995
pubmed:articleTitle
[Treatment and prognosis of stage II testicular seminoma].
pubmed:affiliation
Department of Radiation Oncology, Chinese Academy of Medical Sciences, Beijing.
pubmed:publicationType
Journal Article, Clinical Trial, English Abstract